Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 2026-09-10 pm EDT
|
5-day change | 1st Jan Change | ||
| 14.32 USD | +0.42% |
|
-0.42% | -8.67% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -9.52x | - | -0.04x | - | - | - | - | 1.22B | ||
| 31.26x | 4.18x | 1.17x | 5.63x | 16.88x | 23.61x | 1.04% | 46.05B | ||
| -20.8x | 21.5x | -0.32x | 240.3x | -22.31x | -21.05x | -.--% | 43.59B | ||
| 33.14x | 6.05x | -34.62x | 3.23x | 13.92x | 21.04x | -.--% | 42.35B | ||
| 44.77x | 7.58x | 0.22x | 5.15x | 28.21x | 32.46x | -.--% | 38.86B | ||
| 27.43x | 2.22x | 0.57x | 8.26x | 20.95x | 24.87x | 0.42% | 32.24B | ||
| 33.16x | 23.79x | 2.2x | 5.43x | 24.65x | 25.79x | -.--% | 16.28B | ||
| 23.64x | 2.62x | 0.69x | 2.07x | 8.96x | 13.89x | 1.13% | 14.32B | ||
| 73.03x | 4.33x | -0.32x | 3.87x | 15.02x | 18.45x | -.--% | 13.03B | ||
| 28.12x | 1.33x | 0.27x | 1.86x | 11.4x | 12.99x | -.--% | 12.78B | ||
| 52.17x | 4.55x | 2.73x | 8.66x | 24.57x | 29.3x | 0.44% | 11.3B | ||
| -42.18x | 21.14x | 34.28x | 7.03x | 171.73x | -1556.48x | -.--% | 10.6B | ||
| 38.3x | 4.4x | 2.47x | 4.52x | 19.33x | 31.08x | 0.59% | 10.44B | ||
| -28.28x | 8.32x | 1.06x | 108.93x | -28.66x | -47.4x | -.--% | 10.17B | ||
| -24.37x | 8.42x | -7.98x | 10153.63x | -20.06x | -19.75x | -.--% | 9.45B | ||
| -30.22x | 8.78x | -6.12x | 80.02x | -20.18x | -19.56x | -.--% | 9.73B | ||
| -341.22x | 2.23x | 3.59x | 10.04x | 59.63x | 78.01x | -.--% | 8.92B | ||
| 31.21x | - | -0.1x | 16.33x | 29.8x | 29.11x | -.--% | 9.39B | ||
| -15.32x | 644.25x | -0.29x | 10.02x | -16.08x | -15.52x | -.--% | 9.25B | ||
| Average | -5.04x | 45.63x | -0.03x | 593.05x | 18.76x | -74.40x | 0.2% | 18.42B | |
| Weighted average by Cap. | 10.22x | 25.93x | -2.94x | 315.26x | 15.26x | -33.62x | 0.25% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















